Michael Brines

18.1k total citations · 4 hit papers
160 papers, 12.6k citations indexed

About

Michael Brines is a scholar working on Hematology, Molecular Biology and Physiology. According to data from OpenAlex, Michael Brines has authored 160 papers receiving a total of 12.6k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Hematology, 43 papers in Molecular Biology and 40 papers in Physiology. Recurrent topics in Michael Brines's work include Erythropoietin and Anemia Treatment (69 papers), PARP inhibition in cancer therapy (27 papers) and Vagus Nerve Stimulation Research (17 papers). Michael Brines is often cited by papers focused on Erythropoietin and Anemia Treatment (69 papers), PARP inhibition in cancer therapy (27 papers) and Vagus Nerve Stimulation Research (17 papers). Michael Brines collaborates with scholars based in United States, Italy and Netherlands. Michael Brines's co-authors include Anthony Cerami, Pietro Ghezzi, Davide Agnello, Nihal C. de Lanerolle, Loretta M. Itri, Thomas R. Coleman, Tiziana Mennini, Serhat Erbayraktar, Roberto Latini and Pia Villa and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Michael Brines

158 papers receiving 12.2k citations

Hit Papers

Erythropoietin crosses the blood–brain barrier to protect... 2000 2026 2008 2017 2000 2001 2004 2003 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
    2000 1.2k citations Michael Brines, Pietro Ghezzi et al. Proceedings of the National Academy of Sciences profile →
  2. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
    2001 819 citations Maddalena Fratelli, Michael Brines et al. Proceedings of the National Academy of Sciences profile →
  3. Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor
    2004 527 citations Michael Brines, Giovanni Grasso et al. Proceedings of the National Academy of Sciences profile →
  4. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling
    2003 501 citations Roberto Latini, Pietro Ghezzi et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Brines United States 55 6.2k 2.9k 2.1k 2.0k 1.6k 160 12.6k
Christoph Kleinschnitz Germany 62 2.1k 0.3× 3.4k 1.2× 1.3k 0.6× 697 0.4× 1.9k 1.2× 440 13.8k
Anders Nykjær Denmark 56 875 0.1× 5.3k 1.8× 2.7k 1.3× 786 0.4× 450 0.3× 134 12.7k
Guido Stoll Germany 69 1.9k 0.3× 3.7k 1.3× 1.6k 0.8× 641 0.3× 1.3k 0.9× 258 15.9k
Armin Kurtz Germany 62 757 0.1× 6.1k 2.1× 2.1k 1.0× 907 0.5× 1.2k 0.8× 403 13.2k
Shu‐ichi Ikeda Japan 54 556 0.1× 5.6k 1.9× 2.4k 1.2× 1.1k 0.5× 705 0.5× 515 12.5k
Kenneth D. Bloch United States 75 876 0.1× 6.4k 2.2× 6.0k 2.9× 771 0.4× 1.2k 0.8× 264 18.6k
Thomas E. Willnow Germany 69 573 0.1× 6.8k 2.4× 3.2k 1.6× 930 0.5× 402 0.3× 179 14.7k
Christian Bauer Germany 47 1.9k 0.3× 3.0k 1.1× 2.5k 1.2× 514 0.3× 965 0.6× 166 8.7k
Denis Vivien France 63 1.1k 0.2× 3.8k 1.3× 1.4k 0.7× 631 0.3× 407 0.3× 323 12.4k
Yuqing Huo United States 50 889 0.1× 3.7k 1.3× 985 0.5× 1.0k 0.5× 212 0.1× 146 10.9k

Countries citing papers authored by Michael Brines

Since Specialization
Citations

This map shows the geographic impact of Michael Brines's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Brines with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Brines more than expected).

Fields of papers citing papers by Michael Brines

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Brines. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Brines. The network helps show where Michael Brines may publish in the future.

Co-authorship network of co-authors of Michael Brines

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Brines. A scholar is included among the top collaborators of Michael Brines based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Brines. Michael Brines is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brines, Michael, Xiangying Xue, Prodyot K. Chatterjee, et al.. (2025). Increased plasma lipopolysaccharide-binding protein and altered inflammatory mediators reveal a pro-inflammatory state in overweight women. BMC Women s Health. 25(1). 57–57. 2 indexed citations
2.
Chavan, Sangeeta S., et al.. (2024). Electrical stimulation of the dorsal motor nucleus of the vagus in male mice can regulate inflammation without affecting the heart rate. Brain Behavior and Immunity. 120. 630–639. 7 indexed citations
3.
Morrell, Christopher H., Jack M. Moen, Melissa Krawczyk, et al.. (2023). A small erythropoietin derived non-hematopoietic peptide reduces cardiac inflammation, attenuates age associated declines in heart function and prolongs healthspan. Frontiers in Cardiovascular Medicine. 9. 1096887–1096887. 1 indexed citations
4.
Tsaava, Téa, Arvind Rishi, Valentin A. Pavlov, et al.. (2023). Galantamine ameliorates experimental pancreatitis. Molecular Medicine. 29(1). 149–149. 1 indexed citations
5.
Sangaleti, Carine Teles, Maria Aparecida Dalboni, Nicola Montano, et al.. (2023). Brief periods of transcutaneous auricular vagus nerve stimulation improve autonomic balance and alter circulating monocytes and endothelial cells in patients with metabolic syndrome: a pilot study. SHILAP Revista de lepidopterología. 9(1). 7–7. 13 indexed citations
6.
Yang, Huan, Harold Silverman, Meghan E. Addorisio, et al.. (2021). HMGB1 released from nociceptors mediates inflammation. Proceedings of the National Academy of Sciences. 118(33). 60 indexed citations
7.
Canning, Paul, et al.. (2019). ARA290 (cibinetide) treatment confers neuroprotective effects in diabetic retinopathy, through modulation of inflammatory mediators.. Investigative Ophthalmology & Visual Science. 60(9). 2720–2720. 1 indexed citations
8.
Brines, Michael, Daniel A. Culver, Maryam Ferdousi, et al.. (2018). Corneal nerve fiber size adds utility to the diagnosis and assessment of therapeutic response in patients with small fiber neuropathy. Scientific Reports. 8(1). 4734–4734. 72 indexed citations
9.
Swartjes, Maarten, Monique van Velzen, Marieke Niesters, et al.. (2014). ARA 290, a Peptide Derived from the Tertiary Structure of Erythropoietin, Produces Long-Term Relief of Neuropathic Pain Coupled with Suppression of the Spinal Microglia Response. Molecular Pain. 10. 13–13. 31 indexed citations
10.
Dahan, Albert, Ann Dunne, Maarten Swartjes, et al.. (2013). ARA 290 Improves Symptoms in Patients with Sarcoidosis-Associated Small Nerve Fiber Loss and Increases Corneal Nerve Fiber Density. Molecular Medicine. 19(1). 334–345. 71 indexed citations
11.
O'Leary, Olivia, Emma Reid, Carmel McVicar, et al.. (2013). A novel Erythropoietin-derived peptide regulates Endothelial Progenitor Cell (EPC) mediated retinal vasorepair. Investigative Ophthalmology & Visual Science. 54(15). 4619–4619. 1 indexed citations
12.
Coleman, Thomas R., Christof Westenfelder, Florian Tögel, et al.. (2006). Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities. Proceedings of the National Academy of Sciences. 103(15). 5965–5970. 101 indexed citations
13.
Mennini, Tiziana, Massimiliano De Paola, Paolo Bigini, et al.. (2006). Nonhematopoietic Erythropoietin Derivatives Prevent Motoneuron Degeneration In Vitro and In Vivo. Molecular Medicine. 12(7-8). 153–160. 70 indexed citations
14.
Brines, Michael, Giovanni Grasso, Fabio Fiordaliso, et al.. (2004). Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor. Proceedings of the National Academy of Sciences. 101(41). 14907–14912. 527 indexed citations breakdown →
15.
Ghezzi, Pietro & Michael Brines. (2004). Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death and Differentiation. 11(S1). S37–S44. 265 indexed citations
16.
Eid, Tore & Michael Brines. (2002). Recombinant Human Erythropoietin for Neuroprotection: What Is the Evidence?. Clinical Breast Cancer. 3. S109–S115. 45 indexed citations
17.
Asif, Mohammad, John J. Egan, Sara Vasan, et al.. (2000). An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. Proceedings of the National Academy of Sciences. 97(6). 2809–2813. 262 indexed citations
18.
Wallace, Elizabeth A., et al.. (1996). Clinical case seminar: Cushing's syndrome in an elderly woman with large thyroid and pituitary masses.. The Journal of Clinical Endocrinology & Metabolism. 81(2). 453–456. 2 indexed citations
19.
Bohler, Henry, Ervin E. Jones, & Michael Brines. (1994). Marginally elevated prolactin levels require magnetic resonance imaging and evaluation for acromegaly. Fertility and Sterility. 61(6). 1168–1170.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christoph Kleinschnitz Breakdown of academic impact, for papers by Anders Nykjær Breakdown of academic impact, for papers by Guido Stoll Breakdown of academic impact, for papers by Armin Kurtz Breakdown of academic impact, for papers by Shu‐ichi Ikeda Breakdown of academic impact, for papers by Kenneth D. Bloch Breakdown of academic impact, for papers by Thomas E. Willnow Breakdown of academic impact, for papers by Christian Bauer Breakdown of academic impact, for papers by Denis Vivien Breakdown of academic impact, for papers by Yuqing Huo
Rankless by CCL
2026